Natera logo

Natera

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.

https://www.natera.com/

Company Details

Founded

2004

Employees

4,424 employees

Raised

$1,163,150,080

Public

Yes

Acquired

No

CEO

Steve ChapmanSteve Chapman

Founders

Matthew Rabinowitz
Matthew Rabinowitz
Jonathan Sheena
Jonathan Sheena

Company Collections

These are collections Natera is a part of. Click on the collection name to view similar companies.

Current Job Listings

Listing 0 of 199 job openings

    Total Amount Raised: $1,163,150,080

    Natera Funding Rounds

    • Post Ipo Equity

      $250,000,000

    • Post Ipo Equity

      $400,050,000

    • Post Ipo Equity

      $5,000,000

      Post Ipo Equity Investors

      Matthew Rabinowitz
      Roelof Botha
    • Post Ipo Equity

      $250,000,000

    • Post Ipo Equity

      $104,000,000

    • Series F

      $55,500,000

      Series F Investors

      Sofinnova Investments
      Franklin Resources, Inc.
      Jennison Associates
      RA Capital Management
      HealthCor Partners Management
      OrbiMed Advisors
      Sequoia Capital
    • IPO

      Unknown

    • Series E

      $54,600,000

      Series E Investors

      Harmony Partners
      OrbiMed Advisors
      Founders Fund
      Lightspeed Venture Partners
      Claremont Creek Ventures
      Sequoia Capital
    • Series D

      $20,000,000

      Series D Investors

      Lightspeed Venture Partners
      Claremont Creek Ventures
      Sequoia Capital
    • Grant

      $2,000,000

      Grant Investors

      National Institutes of Health (NIH)
    • Series C

      $12,000,000

      Series C Investors

      Sequoia Capital
    • Series B

      $6,000,000

      Series B Investors

      Claremont Creek Ventures
      Sequoia Capital
      Alafi Capital
    • Series A

      $4,000,000

      Series A Investors

      Claremont Creek Ventures
      Sequoia Capital
    Funding info provided by Diffbot.

    Natera Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Natera.

    Recent reviews